{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:11:13Z","timestamp":1785510673143,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2015\/001268"],"award-info":[{"award-number":["EMR\/2015\/001268"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prp.2026.156439","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:07:50Z","timestamp":1772899670000},"page":"156439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inflammation promotes hepatic but not adipose tissue DGAT2 expression and triglyceride synthesis in MAFLD mice"],"prefix":"10.1016","volume":"282","author":[{"given":"Balasubramaniyan","family":"Vairappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"T.S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156439_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40290-019-00305-z","article-title":"Applying non-invasive fibrosis measurements in NAFLD\/NASH: progress to date","volume":"33","author":"Albhaisi","year":"2019","journal-title":"Pharm. Med."},{"key":"10.1016\/j.prp.2026.156439_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2026.156439_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156439_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lt.25657","article-title":"Nonalcoholic steatohepatitis after liver transplantation","volume":"26","author":"Cotter","year":"2020","journal-title":"Liver Transpl."},{"key":"10.1016\/j.prp.2026.156439_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102377","article-title":"Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics","volume":"48","author":"Alshehade","year":"2024","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156439_bib6","doi-asserted-by":"crossref","first-page":"29247","DOI":"10.1021\/acs.jafc.5c05587","article-title":"Potential effects of functional foods and dietary supplements on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota","volume":"73","author":"Chang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.prp.2026.156439_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2026.156439_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.08.001","article-title":"Role of DGAT enzymes in triacylglycerol metabolism","volume":"655","author":"Bhatt-Wessel","year":"2018","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.prp.2026.156439_bib9","series-title":"Molecular Aspects of Alcohol and Nutrition","first-page":"187","article-title":"Cholesterol regulation by leptin in alcoholic liver disease","author":"Vairappan","year":"2016"},{"key":"10.1016\/j.prp.2026.156439_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinthera.2022.12.008","article-title":"Inhibition of diacylglycerol acyltransferase 2 versus diacylglycerol acyltransferase 1: potential therapeutic implications of pharmacology","volume":"45","author":"Amin","year":"2023","journal-title":"Clin. Ther."},{"key":"10.1016\/j.prp.2026.156439_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1194\/jlr.M013003","article-title":"DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes","volume":"52","author":"Harris","year":"2011","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.prp.2026.156439_bib12","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1038\/s41598-018-23223-7","article-title":"The role of diacylglycerol acyltransferase (DGAT) 1 and 2 in cardiac metabolism and function","volume":"8","author":"Roe","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156439_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/dom.12221","article-title":"Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial","volume":"16","author":"Denison","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.prp.2026.156439_bib14","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1074\/jbc.M311000200","article-title":"Jr., Lipopenia and skin barrier abnormalities in DGAT2-deficient mice","volume":"279","author":"Stone","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156439_bib15","doi-asserted-by":"crossref","first-page":"9820","DOI":"10.1021\/jm4007033","article-title":"Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors","volume":"56","author":"DeVita","year":"2013","journal-title":"J. Med Chem."},{"key":"10.1016\/j.prp.2026.156439_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(20)30186-2","article-title":"Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"5","author":"Loomba","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156439_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.prp.2026.156439_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/13543776.2018.1459569","article-title":"Farnesoid X receptor modulators 2014-present: a patent review","volume":"28","author":"Sepe","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.prp.2026.156439_bib19","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156439_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156439_bib21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jhep.2013.01.023","article-title":"Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure","volume":"58","author":"Balasubramaniyan","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156439_bib22","doi-asserted-by":"crossref","first-page":"G389","DOI":"10.1152\/ajpgi.00181.2022","article-title":"Myeloid-specific fatty acid transport protein 4 deficiency induces a sex-dimorphic susceptibility for nonalcoholic steatohepatitis in mice fed a high-fat, high-cholesterol diet","volume":"324","author":"Gocebe","year":"2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.prp.2026.156439_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176010","article-title":"Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF","volume":"958","author":"Vairappan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prp.2026.156439_bib24","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.30765","article-title":"Hepatocyte deletion of triglyceride-synthesis enzyme Acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice","volume":"70","author":"Gluchowski","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2026.156439_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.149126","article-title":"Nimbolide attenuates hepatocellular carcinoma by regulating miRNAs 21, 145 and 221 and their target gene expression","volume":"937","author":"Vairappan","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.prp.2026.156439_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156439_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.lfs.2005.05.079","article-title":"Intraperitoneal leptin regulates lipid metabolism in ethanol supplemented Mus musculas heart","volume":"78","author":"Balasubramaniyan","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2026.156439_bib28","first-page":"486","article-title":"A new method for the direct determination of serum cholesterol","volume":"41","author":"Zlatkis","year":"1953","journal-title":"J. Lab Clin. Med"},{"key":"10.1016\/j.prp.2026.156439_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/19.3.338","article-title":"Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method","volume":"19","author":"Foster","year":"1973","journal-title":"Clin. Chem."},{"key":"10.1016\/j.prp.2026.156439_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(73)90016-8","article-title":"An easy colorimetric micromethod for routine determination of free fatty acids in plasma","volume":"46","author":"Falholt","year":"1973","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2026.156439_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.dld.2024.08.050","article-title":"NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension","volume":"57","author":"Vairappan","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.prp.2026.156439_bib32","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1074\/jbc.274.24.16825","article-title":"Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake","volume":"274","author":"Gao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156439_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbalip.2008.01.001","article-title":"Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice","volume":"1781","author":"Liu","year":"2008","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.prp.2026.156439_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav9701","article-title":"Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis","volume":"11","author":"Amin","year":"2019","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.prp.2026.156439_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2026.156439_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2026.156439_bib37","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.prp.2026.156439_bib38","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2026.156439_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.01.011","article-title":"DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER","volume":"36","author":"Rong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156439_bib40","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","article-title":"ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials","volume":"27","author":"Calle","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2026.156439_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.20783","article-title":"Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice","volume":"42","author":"Yu","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2026.156439_bib42","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance","volume":"282","author":"Choi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156439_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(25)00979-1","article-title":"I.C. Investigators, Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"406","author":"Loomba","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156439_bib44","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1152\/ajpendo.00040.2002","article-title":"ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts","volume":"283","author":"Imamura","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2026.156439_bib45","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1053\/j.gastro.2007.02.046","article-title":"Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide","volume":"132","author":"Imai","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2026.156439_bib46","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.90204.2008","article-title":"Inhibition of ADRP prevents diet-induced insulin resistance","volume":"295","author":"Varela","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.prp.2026.156439_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2014.05.072","article-title":"Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction","volume":"450","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156439_bib48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00535-007-2119-8","article-title":"Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice","volume":"42","author":"Ohhira","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156439_bib49","unstructured":"M.F. Liu, L.X. Zu, C. Xu, S.S. Pu, G.H. Xu, [Tumor necrosis factor-alpha upregulates the protein levels of adipose differentiation-related protein in rat differentiated adipocytes], Beijing Da Xue Xue Bao Yi Xue Ban. 40 (2008) 578-582."},{"key":"10.1016\/j.prp.2026.156439_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jdiacomp.2012.10.008","article-title":"Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes","volume":"27","author":"Doycheva","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.prp.2026.156439_bib51","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.prp.2026.156439_bib52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3892\/etm.2021.10262","article-title":"Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice","volume":"22","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2026.156439_bib53","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1194\/jlr.M600471-JLR200","article-title":"NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes","volume":"48","author":"Laurencikiene","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prp.2026.156439_bib54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.14492","article-title":"C.R.N. Nash, Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis","volume":"47","author":"Hameed","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.prp.2026.156439_bib55","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","article-title":"Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis","volume":"79","author":"Sanyal","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2026.156439_bib56","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.biopha.2017.11.083","article-title":"Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation","volume":"96","author":"Xiong","year":"2017","journal-title":"Biomed. Pharmacother."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:35:15Z","timestamp":1785508515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S0344033826000907"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156439","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation promotes hepatic but not adipose tissue DGAT2 expression and triglyceride synthesis in MAFLD mice","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156439"}}